| Document |
Document Title |
|
WO/2024/085482A1 |
The present invention relates to a novel Metarhizium pinghaense 15R strain with insecticidal and bactericidal activity, and a use thereof. Specifically, the present invention relates to a novel Metarhizium pinghaense 15R strain that exhi...
|
|
WO/2024/083954A1 |
A method of processing spent brewer's yeast (BSY) to a fermented BSY product is described. The BSY product is a pleasant tasting, nutritious and functional ingredient which enables the ingredient to be used for human consumption in foods...
|
|
WO/2024/085081A1 |
Provided is an antibody that specifically binds to the extracellular domain of human LPA1 but does not specifically bind to the extracellular domain of human LPA2 or the extracellular domain of human LPA3. The antibody preferably has act...
|
|
WO/2024/083600A1 |
In the present invention new Bacillus strains are provided. More specifically, Bacillus strains having extracellular hydrolase activity and demonstrating reduced malodor after incubation for at least 5 days for at least 25 °C in a lacto...
|
|
WO/2024/084510A1 |
The present invention relates to a cost-effective process for the synthesis of hyper-production of poly gamma glutamic acid using L-glutamic acid independent approach. Specifically, the present invention relates to the synthesis of poly ...
|
|
WO/2024/084851A1 |
A plasmalogen production–promoting culture medium according to the present invention includes lactose as a carbon source and is to be used to culture lactic acid bacteria.
|
|
WO/2024/083910A1 |
The present invention relates to a new bacterial strain and a new urolithin named urolithin G. The new strain of the invention is Enterocloster bolteae CEBAS S4A9 DSM 34392 and can customize urolithin production to mimic metabotype A and...
|
|
WO/2024/084779A1 |
A culture control device 8 includes: a calculation unit 18 that calculates a rate at which cells 10 in a culture medium 12 consume glucose, a rate at which the cells 10 produce lactic acid, and a glycolysis ratio, which is the ratio of t...
|
|
WO/2024/082334A1 |
Provided are a melt electrowriting-based carbon fiber-silk fibroin composite material for microbial culture and a preparation method therefor, relating to the field of microbial culture. Silk fibroin, diatomite powder, and high polymer p...
|
|
WO/2024/083273A1 |
Flowering-inducing composition containing bacteria from Brevibacterium celere C-924 strain and excipients or stabilizers. The mentioned agent can increase the number of flowers and produce an earlier inflorescence in cultivated plants. A...
|
|
WO/2024/084054A1 |
The present invention relates to a live attenuated Gram-negative bacterium comprising a modified hlyCABD operon, wherein the modified hlyCABD operon is split into a first segment and a second segment, each segment being operably linked t...
|
|
WO/2024/085425A1 |
The present invention relates to a method for producing a microalgae concentrate with low viscosity, the method comprising a step of adjusting the pH of a microalgae fermentation broth and a heat treatment step, in which utility costs an...
|
|
WO/2024/083061A1 |
The present invention belongs to the cross technique field of plant-microorganism, and specifically relates to a method for breeding an improved variety of a forage sorghum-bacillus megaterium symbiont. The method comprises the following...
|
|
WO/2024/082327A1 |
A method for efficiently purifying phospholipid from coenzyme Q10 fermented powder, comprising the following steps: 1) mother liquor culture, 2) seed tank culture, 3) fermentation tank culture, 4) fermented liquor centrifugation, 5) high...
|
|
WO/2024/086846A1 |
Compositions comprising one or more peptide antigens for immunizing an avian animal against C. hepaticus, or a vector for expressing the one or more peptide antigens in vivo are disclosed. Methods of immunizing an avian animal against C....
|
|
WO/2024/082757A1 |
Provided are the use of chlorflavonin and derivatives thereof, in particular the use thereof in inhibiting the growth of microorganisms and inhibiting the growth of plants. Also provided are genes associated with the synthesis of flavone...
|
|
WO/2024/083185A1 |
The application relates to an isolated monoclonal antibody that specifically binds FGFR2B, or an antigen binding portion thereof. The application also relates to a nucleic acid molecule encoding the antibody or antigen binding portion th...
|
|
WO/2024/085483A1 |
The present invention relates to a novel Beauveria bassiana 331R strain with insecticidal and bactericidal activity and use thereof and, in particular, to a novel Beauveria bassiana 331R strain (Accession No.: KACC83066BP) having control...
|
|
WO/2024/085310A1 |
The present invention relates to a novel microbe that can decompose plastic and a plastic decomposition method using same. The microbe can decompose at least one plastic selected from the group consisting of PET, PVC, PS, PP and PE under...
|
|
WO/2024/084197A1 |
The invention relates to methods for reducing the level of xenobiotic in an environment by contacting the environment with a composition comprising one or more bacterial strains. The invention also relates to bacterial strains for use in...
|
|
WO/2024/084023A1 |
The present invention relates to a chip for micro-organism lysis comprising a lysing chamber and valves, a mechanical system operating with such chip and methods of microorganism lysing.
|
|
WO/2024/079840A1 |
The purpose is to provide a method for controlling a culture device that permits conducting culture under a more suitable culture environment. The method for controlling a culture device 1 that inputs a set value SV that sets the cultu...
|
|
WO/2024/078038A1 |
Provided in the present invention are a wheat leaf rust resistance protein, and an encoding gene and the use thereof The wheat leaf rust resistant protein comprises any one of the following (a)-(c): (a) a protein, which consists of the a...
|
|
WO/2024/050376A3 |
Described herein is a novel enzymatic pathway and acid tolerant Schizosaccharomyces pombe strain exhibiting the same, for producing 3-hydroxypropionic acid by fermentation wherein the S. pombe strain includes nucleotide sequences that en...
|
|
WO/2024/080441A1 |
The present invention provides: a Paracoccus aminovorans BM109 strain (accession number KCTC 15059BP), which is excellent for removing trimethylamine (TMA) or trimethylamine N-oxide (TMAO); and a pharmaceutical composition for preventing...
|
|
WO/2024/025875A3 |
Certain emboidments provide a method of promoting regeneration of one or more intestinal stem cells in a mammalian organoid culture, the method comprising treating the organoid culture with an effective amount of transforming growth fact...
|
|
WO/2024/078561A1 |
The present invention belongs to the technical fields of microorganisms and cosmetics, and particularly relates to a Bifidobacterium animalis strain and the use thereof. Experiments prove that a supernatant of a fermentation broth of the...
|
|
WO/2024/077702A1 |
An alkaline protease mutant having an improved enzyme activity obtained by means of iterative saturation mutagenesis using overlapping PCR technology, and a preparation therefor and the use thereof. The alkaline protease gene apr from Ba...
|
|
WO/2024/081915A1 |
The present disclosure provides capture proteins for detection of antibodies specific for Kawasaki disease, methods of using the antibodies, and kits comprising the same.
|
|
WO/2024/079228A1 |
The invention relates to the field of dairy technology. The invention specifically relates to a Streptococcus thermophilus starter strain and composition comprising such strain, to methods to produce a fermented milk product using such s...
|
|
WO/2024/078463A1 |
Provided is a microbial system established based on a genetically modified bacterial strain under a genus of Pseudomonas with improved capacities to form more biofilms and trap more microplastics from a source than its wild-type form. In...
|
|
WO/2024/080409A1 |
The present invention relates to a method for manufacturing vegetable tanned leather using mushroom mycelium, the method being characterized by comprising: a first step of preparing a net structure fabric; a second step of impregnating t...
|
|
WO/2024/080626A1 |
Disclosed are: a Bacillus licheniformis JWS22003 strain (accession number: KACC 92452P) for promoting fermentation of by-products, auxin production, and plant growth; a method for promoting fermentation of by-products and plant growth by...
|
|
WO/2024/077445A1 |
Provided are a 5'UTR element comprising a nucleotide sequence as shown in SEQ ID NO: 11 and the use thereof in the production of L-arginine. Further provided are a functional expression element containing the 5'UTR element and a promoter...
|
|
WO/2024/044069A3 |
Solid freeze-dried animal treat compositions and methods of preparing and using the treats are disclosed. The animal treats comprise a yeast product and an Aspergillus sp. product.
|
|
WO/2024/077428A1 |
Provided is an enzyme with D-amino acid synthesis activity. The enzyme has an amino acid sequence as shown in SEQ ID NO: 10. Compared with an original strain before mutation, the enzyme has a higher catalytic activity for D-amino acid sy...
|
|
WO/2023/086502A9 |
Described in several exemplary embodiments herein are serum replacement compositions, cell culture media containing said serum replacement compositions, and uses thereof.
|
|
WO/2024/054921A3 |
The present disclosure relates to microorganisms useful in the biosynthesis of psicose. Also provided are methods of producing the disclosed microorganism and methods of producing psicose.
|
|
WO/2024/079114A1 |
The invention relates to the field of recombinant production of proteins in host cells. In particular, the invention relates to processes for manufacturing recombinant proteins in host cells which processes reduce the misincorporation of...
|
|
WO/2024/074714A1 |
The present invention provides a method for increasing the growth efficiency in an anaerobic microbial fermentation of a microorganism capable of converting CO2, CO or a mixture thereof into at least one organic compound, the method comp...
|
|
WO/2024/076509A1 |
A process and system for producing a nutrient supplement from an anaerobic fermentation process comprising fermenting in a gaseous substrate with an acetogenic culture. The process comprises recovering an oxygenated hydrocarbon and incub...
|
|
WO/2024/074105A1 |
The present invention belongs to the field of biopharmaceuticals. Provided in the present invention are keratin YK93-4, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell contain...
|
|
WO/2024/075597A1 |
Provided is a method for manufacturing a copolymer polyhydroxyalkanoic acid mixture by culturing a microorganism. The mixture contains: a fraction (I) which includes a copolymer polyhydroxyalkanoic acid having a 3-hydroxybutyric acid str...
|
|
WO/2024/077194A2 |
The invention relates to direct-fed microbials for use in improving the performance of an animal and improving the health of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus coagulans str...
|
|
WO/2024/077121A1 |
Oral care compositions that contain a particular mixture of mono-rhamnolipids and dirhamnolipids are disclosed. The compositions have antimicrobial efficacy against oral microbes, such as P. gingivalis, S. mutans, and C. rectus. Also dis...
|
|
WO/2024/075722A1 |
The present invention provides: a method for culturing adhesive cells using a microcarrier coated with a polymer that exhibits a lower critical temperature within a culture vessel, wherein the method is characterized by including the fol...
|
|
WO/2024/075997A1 |
The present invention provides a microalgae production system via a culture solution spraying method under an anhydrous cultivation condition, Haematococcus cultivated therethrough, and astaxanthin obtained by Haematococcus, wherein the ...
|
|
WO/2024/074540A2 |
The invention relates to a genetically engineered cell and compositions comprising said cell, wherein said cell is engineered to be especially sensitive towards two or more environmental factors, to enhance the biosafety profile of said ...
|
|
WO/2024/074102A1 |
The present invention pertains to the field of biopharmaceuticals and provides a keratin YK93-6, a nucleic acid molecule encoding same, an expression vector comprising the nucleic acid molecule, a host cell that contains the expression v...
|
|
WO/2024/074604A1 |
The present invention relates to compound of general formula (I): wherein the variables take the various meanings, pharmaceutical compositions containing them and their use in medicine, particularly in cancer such as Glioblastoma. The co...
|
